The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ERIC 2020 | The origins of mutated and unmutated CLL
Freda Stevenson, MSc, DPhil, FRCPath, FMedSci, University of Southampton, Southampton, UK, describes the origins of the two forms of chronic lymphocytic leukemia (CLL); mutated and unmutated. Mutated CLL originates from a relationship with monoclonal B-cell monocytosis and does not generally require therapy. The origins of unmutated CLL reflect the body’s innate antibody reaction and requires therapy. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.
